Browsing eNauka
Browsing by Author Budincevic, Hrvoje
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension | Oh, Jiwon; Drulović, Jelena S.  ; Dufek, Michal; Budincevic, Hrvoje; Habek, Mario; Caunt, Maresa; Cheng, Ying-Fang; Harp, Christopher; Sierzega, Malgorzata; Clayton, David;
Ratchford, John; Goodyear, Alexandra; Bar-Or, Amit;
| Conference Paper | Mp. category will be shown later |
| 2025 | Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension | Bar-Or, Amit; Oh, J.; Dufek, Michal; Budincevic, Hrvoje; Habek, Mario; Caunt, Maresa; Harp, C.; Sierzega, M.; Clayton, David; Chen, Y.;
Ratchford, JN; Goodyear, Alexandra; Drulović, Jelena S.
; | Conference Paper | Mp. category will be shown later |
| 2024 | Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension | Bar-Or, Amit; Oh, Jiwon; Dufek, Michal; Budincevic, Hrvoje; Habek, Mario; Caunt, Maresa; Thomas, Piia; Sierzega, Malgorzata; Clayton, David; Cheng, Ying Fang;
Ratchford, John; Goodyear, Alexandra; Drulović, Jelena S.
; | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2023 | The cost of ischaemic stroke in Croatia | Benkovic, Vanesa; Parker, Mark; Novakovic, Tanja; Mestrovic, Andrija; Budincevic, Hrvoje | Naučni članak | 21aM21a |